SlideShare a Scribd company logo
1 of 53
Download to read offline
Skin Cancers. Malignant Melanoma.
Igor Y. Galaychuk, MD, DSc,
Professor, Head of Oncology
and Radiology Department,
Ternopil State Medical University
Statistical data:
More than 1 million cases of skin cancer
will be diagnosed in the United States
every year. About 80 % of these new
skin cancer cases will be basal cell
carcinoma, 16 % will be squamous cell
carcinoma, and only 4 % will be
malignant melanoma.
Definition:
Cutaneous malignant
melanoma is a
neoplasm arising from
the melanocytes that
can occur de novo or
from a preexisting
lesion such as a
congenital, acquired, or
atypical (dysplastic)
nevus.
Biologic progression of melanoma
Melanocyte  nevus 
dysplastic nevus  меlanoма “in situ” 
superficial spreading melanoma 
nodular melanoma  metastatic
melanoma
Professional education:
students
family doctors
dermatologists
surgeons
cosmetologists
morphologists
oncologists !
nurses
ABCD-test
Screening:
Self-Examination for Melanoma:
examine your body front and back in
the mirror, arms and palms, legs and
feet, neck and scalp –
If you have any doubt about a mole,
see a dermatologist-oncologist
(American Academy of Dermatology)
Malignant Melanoma: Risk Factors
Age > 40 yr.
Race: white
Sun exposure: UVA, UVB
Hereditary factors:
“melanoma families“,
atypical mole syndrome or
dysplastic nevus syndrome
Trauma of moles,
Giant congenital nevi
Oncogene mutations
Dysplastic Nevi (Atypical Moles)
Atypical moles are not
melanoma, but they can
become melanoma. They can
be found in sun-exposed or sun-
protected areas of the body.
Atypical moles are larger and
more irregular in shape, with
notched or fading borders. They
may be flat or raised or the
surface smooth or rough. They
are typically of mixed color,
including pink, red, tan, and
brown.
Precursor Lesions
ABCDE rules:
'A' is Asymmetry
Asymmetry means one half
of a mole does not match
the other half. Normal moles
are symmetrical. When
checking your moles or
freckles, draw an imaginary
line through the middle and
compare the two halves. If
they do not look the same
on both sides, have it
checked by a dermatologist.
'B' is for Border
If the border or
edges of the mole
are ragged, blurred,
or irregular, have it
checked by a
dermatologist.
Melanoma lesions
often have uneven
borders.
'C' is for Colour
A mole that does not
have the same color
throughout or that has
shades of tan, brown,
black, blue, white, or
red is suspicious.
Normal moles are
usually a single shade
of color. A mole of
many shades or that
has lightened or
darkened should be
checked by a doctor.
'D' is for Diameter
A mole is suspicious
if the diameter is
larger than 6 mm.
Benign moles are
usually less than 6
millimeters in
diameter.
'E' is for Evolving
A mole that is evolving
– shrinking, growing
larger, changing color,
begins to itch or bleed –
should also be checked.
If a portion of the mole
appears elevated, or
raised from the skin,
have it looked at by a
doctor. Melanoma
lesions often grow in
size or change in height
rapidly.
ABCDE: summary
Asymmetry of lesion;
Border irregularity;
Color change;
Diameter larger than
6 mm;
Evolving (surface
changes [raised,
bleeding, crusting] or
symptomatic [itchiness
or tenderness]).
Melanoma can vary in appearance
Dermatoscopy:
Dermatoscopy: ABCD
ЕЛМ
Diagnostics system MoleMax:
Growth patterns of melanoma:
superficial spreading melanoma – 70%
nodular melanoma – 15-20%
lentigo maligna melanoma – 4 -10%
acral lentigo-melanoma – 2-8%
amelanotic melanoma – 5%
Biopsy techniques
For cytological exam:
- fine-needle aspiration,
- superficial scraping.
For histological exam:
- complete excision
(Breslow’s thickness,
Clark’ levels)
Thickness of melanoma
TNM:
T1 < 1 mm
T2 1-2 mm
T3 2-4 mm
T4 > 4 mm
Radial growth phase
Vertical growth phase
Evaluation for Metastasis: N0-3, M0-1
Regional Lymph Nodes:
N0 – no metastasis,
N1 – one lymph node with metastasis,
N2 – 2-3 lymph nodes with Mts.,
N3 – 4 and > metastatic lymph nodes.
Distant Metastasis: M0 – no metastasis,
M1a: Mts in subcutaneous tissue,
M1b: Mts in lung,
M1c: Mts in other visceral organs (brain, liver, etc)
Surgical treatment of primary melanoma Т3bN1аМ0:
wide local excision with wound plasty.
Postoperative wound closed by flaps’
transposition.
melanoma Wide local
excision
Sentinel node biopsy,
or regional lymph node
dissection
Metastatic cells
Surgical approach to lymphogenous metastases of melanoma
Surgery of regional lymph nodes
Elective lymph node dissection is defined as removing
regional lymph nodes that drain the site of the
primary melanoma in the absence of any clinical
evidence of nodal metastases. Elective lymph node
dissection is a much-debated topic in the
management of melanoma.
Sentinel lymph node biopsy, a staging and possibly
therapeutic procedure, is the most powerful predictor
of melanoma recurrence and survival. Initially,
lymphoscintigraphy is used to precisely map the
draining nodal basin.
Therapeutic regional lymph node dissection carried
out when clinically present metastatic lymph nodes.
Lentigo maligna melanoma
(arise from Hutchinson’s freckle)
1 year after Radiation Therapy
Melanoma: scars, recurrence, in transit Mts
1
3
2
4
Metastatic melanoma
Palliative  - therapy
Hormonotherapy
Supportive care
Survival rates:
J Clin Oncol 2001;19:3635-3648.
Melanoma in situ: 100% survival at 5 years and 10 years.
Lesions ≤1 mm: 91%–95% at 5 years; 83%–88% at
10 years
Lesions 1.01–2 mm: 77%–89% at 5 years; 64%–79% at
10 years
Lesions 2.01–4 mm: 63%–79% at 5 years; 51%–64% at
10 years
Lesions >4 mm: 45%–67% at 5 years; 32%–54% at
10 years
Skin cancers
More than 1 million estimated new
nonmelanoma skin cancers were
diagnosed in the United States in
2005, a number that was nearly
equivalent to the number of all
other cancers diagnosed in the US
the same year.
Of these cases, approximately 80%
are basal cell carcinoma (BCC) and
20% are squamous cell carcinoma
(SCC), making cutaneous SCC the
second most common skin cancer
and one of the most common
cancers overall in the US.
BCC, T1
The following are exposure-related risk factors
in the development of cutaneous cancers:
UV radiation exposure (high cumulative dose of
sunshine, tanning beds, or medical UV treatments)
Immunosuppression (eg, HIV), including iatrogenic
immunosuppression (eg, transplant recipients)
Ionizing radiation (eg, medical treatments,
occupational or accidental radiation exposure)
Infections (eg, HPV, osteomyelitis, acne conglobata,
hidradenitis suppurativa, dissecting cellulitis of scalp,
lupus vulgaris, lymphogranuloma venereum,
granuloma inguinale, and chronic deep fungal
infection)
Chemical carcinogens (eg, arsenic, tar, polyaromatic
hydrocarbons)
Host responses that influence cutaneous SCC
development include the following:
Genetic susceptibility and dermatoses (eg, xeroderma
pigmentosum, dystrophic epidermolysis bullosa,
epidermodysplasia verruciformis, xeroderma pigmentosum,
oculocutaneous albinism, dyskeratosis congenita,
porokeratosis [Mibelli type, disseminated superficial actinic
type, linear type], nevus sebaceous, and KID syndrome
[keratitis, ichthyosis, deafness])
Susceptibility to UV radiation (eg, fair skin [Fitzpatrick skin
types I and II], blond or red hair, light-colored eyes)
Chronic inflammation, such as nonhealing burns or scars
(eg, Marjolin ulcer, burn scar or thermal injury, venous
ulcer, lymphedema, discoid lupus erythematosus, erosive
oral lichen planus, lichen sclerosis et atrophicus, mutilating
keratoderma, and necrobiotic lipoidica)
The biggest cause of skin cancer is sun
exposure
SCC in situ:
Clinically, lesions of SCC in situ
(SCCIS) range from a scaly pink
patch to a thin keratotic papule
or plaque similar to an actinic
keratosis.
Bowen disease is a subtype of
SCCIS characterized by a sharply
demarcated pink plaque arising
on non–sun-exposed skin (see
the first image below).
Erythroplasia of Queyrat refers to
Bowen disease of the glans
penis, which manifests as one or
more velvety red plaques
Every patient with suspected skin carcinoma
should undergo a comprehensive examination,
including the following:
Location of lesion
Size of lesion
Character of lesion
(smooth/nodular, vascularity,
color) – SCC may appear as
plaques or nodules with variable
degrees of scale, crust, or
ulceration
Presence of ulceration
Evaluation of subcutaneous
tissues (depth of lesion, bony
involvement)
Palpation of regional lymph
nodes
Methods of morphological confirmation of
skin cancer:
For cytological exam:
- superficial scraping
- fine-needle aspiration
For histological exam:
complete excision
(Breslow’s thickness,
Clark’ levels)
High-risk tumor features include the
following:
Greater than 2 mm
thickness or Clark level IV
or higher
Perineural invasion
Primary anatomic location
on the ear or non–hair-
bearing lip
Poorly differentiated or
undifferentiated cellular
histology
Precancerous lesions: Actinic (Solar) Keratosis)
These small, scaly patches are
caused by too much sun, and
commonly occur on the head,
neck, or hands, but can be
found elsewhere. They can be
an early warning sign of skin
cancer, but it's hard to tell
whether a particular patch will
continue to change over time
and become cancerous. Most do
not, but we recommend early
treatment to prevent the
development of squamous cell
skin cancer. Fair-skinned, blond,
or red-haired people with blue or
green eyes are most at risk.
Cutaneous Horns
The cutaneous horn appears as
a funnel-shaped growth that
extends from a red base on the
skin. It is composed of
compacted keratin. The size and
shape of the growth can vary
considerably, but most are a
few millimeters in length.
Squamous cell carcinoma can
be found at the base. It usually
occurs in fair-skinned elderly
adults with a history of
significant sun exposure.
Skin cancer
Clinical case:
Basal Cell Carcinoma,
T1N0M0
(ulcer pattern)
Basal Cell Carcinoma
Basal cell carcinoma is the most
common and easiest-to-treat
skin cancer. Because basal cell
carcinoma spreads slowly, it
occurs mostly in adults. Basal
cell tumors can take on many
forms, including a pearly white
or waxy bump, often with
visible blood vessels, on the
ears, neck, or face. Tumors can
also appear as a flat, scaly,
flesh-colored or brown patch on
the back or chest, or more
rarely, a white, waxy scar.
Skin cancer
Clinical case:
Ear Squamous Cell
Carcinoma,
T4N0M0
TNM-Classification of Skin Cancer:
Тis – carcinoma in situ
Т1 –  2 cm
Т2 – 2 - 5 cm
Т3 – > 5 см
Т4 – t-r invades cartilage, muscle, or
bone.
N0, N1
M0, M1
Skin Cancer
Squamous Cell
Carcinoma of lower
eyelid with invasion
in bulbar
conjunctiva,
T4N0M0
Skin Cancer
Squamous Cell
Carcinoma of Cheek,
T4N0M0
Skin Cancer
Results after
half course of
gamma-
therapy, 45 Gy
SCC of back: scheme of surgery
Surgery of skin cancer: flap plasty of wound
after complete excision of cancer
Skin Squamous Cell Cancer of Neck:
Postoperative wound is temporary
covered with Pig skin xenografts
T4NxM0
Skin Cancer:
granulation wound (1), skin autografting (2)
14 day: wound after removing of xenografts
Skin Cancer: complete recovery
12 months later
Тернопільське озеро
Дякую за увагу!

More Related Content

Similar to 01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf

20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
SDGWEP
 
melignantmelanomjjnjnjnjniijjnikkja.pptx
melignantmelanomjjnjnjnjniijjnikkja.pptxmelignantmelanomjjnjnjnjniijjnikkja.pptx
melignantmelanomjjnjnjnjniijjnikkja.pptx
avimarodkar
 

Similar to 01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf (20)

MALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdfMALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdf
 
Mailgnant melanoma
Mailgnant melanoma Mailgnant melanoma
Mailgnant melanoma
 
Skin cancer
Skin cancerSkin cancer
Skin cancer
 
Cutaneous malignancies
Cutaneous malignanciesCutaneous malignancies
Cutaneous malignancies
 
Skin cancer
Skin cancerSkin cancer
Skin cancer
 
Surgical Treatment of Malignant Melanoma-1.ppt
Surgical Treatment of Malignant Melanoma-1.pptSurgical Treatment of Malignant Melanoma-1.ppt
Surgical Treatment of Malignant Melanoma-1.ppt
 
Basics of wounds, lumps, bumps, and rashes for gwep 2018
Basics of wounds, lumps, bumps, and rashes for gwep 2018Basics of wounds, lumps, bumps, and rashes for gwep 2018
Basics of wounds, lumps, bumps, and rashes for gwep 2018
 
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
 
melignantmelanomjjnjnjnjniijjnikkja.pptx
melignantmelanomjjnjnjnjniijjnikkja.pptxmelignantmelanomjjnjnjnjniijjnikkja.pptx
melignantmelanomjjnjnjnjniijjnikkja.pptx
 
Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptx
 
Biology Capstone Project Example
Biology Capstone Project ExampleBiology Capstone Project Example
Biology Capstone Project Example
 
Skin Cancer.pptx
Skin Cancer.pptxSkin Cancer.pptx
Skin Cancer.pptx
 
Tumors of the eye
Tumors of the eyeTumors of the eye
Tumors of the eye
 
Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptx
 
Malignant melanoma Dr chithra p
Malignant melanoma Dr chithra pMalignant melanoma Dr chithra p
Malignant melanoma Dr chithra p
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)
 
Tumor of oral cavity
Tumor of oral cavityTumor of oral cavity
Tumor of oral cavity
 
Dr. Treacy's Casebook: Treating Squamous Cell Cancer
Dr. Treacy's Casebook: Treating Squamous Cell CancerDr. Treacy's Casebook: Treating Squamous Cell Cancer
Dr. Treacy's Casebook: Treating Squamous Cell Cancer
 
Melanoma
MelanomaMelanoma
Melanoma
 
Neoplasia - Patholgy
Neoplasia - Patholgy Neoplasia - Patholgy
Neoplasia - Patholgy
 

Recently uploaded

PODOCARPUS...........................pptx
PODOCARPUS...........................pptxPODOCARPUS...........................pptx
PODOCARPUS...........................pptx
Cherry
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
Cherry
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
Cherry
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
Cherry
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
Cherry
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
ANSARKHAN96
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
Cherry
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
Scintica Instrumentation
 

Recently uploaded (20)

PODOCARPUS...........................pptx
PODOCARPUS...........................pptxPODOCARPUS...........................pptx
PODOCARPUS...........................pptx
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
Terpineol and it's characterization pptx
Terpineol and it's characterization pptxTerpineol and it's characterization pptx
Terpineol and it's characterization pptx
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.
 
FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
Genome organization in virus,bacteria and eukaryotes.pptx
Genome organization in virus,bacteria and eukaryotes.pptxGenome organization in virus,bacteria and eukaryotes.pptx
Genome organization in virus,bacteria and eukaryotes.pptx
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdf
 

01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf

  • 1. Skin Cancers. Malignant Melanoma. Igor Y. Galaychuk, MD, DSc, Professor, Head of Oncology and Radiology Department, Ternopil State Medical University
  • 2. Statistical data: More than 1 million cases of skin cancer will be diagnosed in the United States every year. About 80 % of these new skin cancer cases will be basal cell carcinoma, 16 % will be squamous cell carcinoma, and only 4 % will be malignant melanoma.
  • 3. Definition: Cutaneous malignant melanoma is a neoplasm arising from the melanocytes that can occur de novo or from a preexisting lesion such as a congenital, acquired, or atypical (dysplastic) nevus.
  • 4. Biologic progression of melanoma Melanocyte  nevus  dysplastic nevus  меlanoма “in situ”  superficial spreading melanoma  nodular melanoma  metastatic melanoma
  • 6. Screening: Self-Examination for Melanoma: examine your body front and back in the mirror, arms and palms, legs and feet, neck and scalp – If you have any doubt about a mole, see a dermatologist-oncologist (American Academy of Dermatology)
  • 7. Malignant Melanoma: Risk Factors Age > 40 yr. Race: white Sun exposure: UVA, UVB Hereditary factors: “melanoma families“, atypical mole syndrome or dysplastic nevus syndrome Trauma of moles, Giant congenital nevi Oncogene mutations
  • 8. Dysplastic Nevi (Atypical Moles) Atypical moles are not melanoma, but they can become melanoma. They can be found in sun-exposed or sun- protected areas of the body. Atypical moles are larger and more irregular in shape, with notched or fading borders. They may be flat or raised or the surface smooth or rough. They are typically of mixed color, including pink, red, tan, and brown. Precursor Lesions
  • 9. ABCDE rules: 'A' is Asymmetry Asymmetry means one half of a mole does not match the other half. Normal moles are symmetrical. When checking your moles or freckles, draw an imaginary line through the middle and compare the two halves. If they do not look the same on both sides, have it checked by a dermatologist.
  • 10. 'B' is for Border If the border or edges of the mole are ragged, blurred, or irregular, have it checked by a dermatologist. Melanoma lesions often have uneven borders.
  • 11. 'C' is for Colour A mole that does not have the same color throughout or that has shades of tan, brown, black, blue, white, or red is suspicious. Normal moles are usually a single shade of color. A mole of many shades or that has lightened or darkened should be checked by a doctor.
  • 12. 'D' is for Diameter A mole is suspicious if the diameter is larger than 6 mm. Benign moles are usually less than 6 millimeters in diameter.
  • 13. 'E' is for Evolving A mole that is evolving – shrinking, growing larger, changing color, begins to itch or bleed – should also be checked. If a portion of the mole appears elevated, or raised from the skin, have it looked at by a doctor. Melanoma lesions often grow in size or change in height rapidly.
  • 14. ABCDE: summary Asymmetry of lesion; Border irregularity; Color change; Diameter larger than 6 mm; Evolving (surface changes [raised, bleeding, crusting] or symptomatic [itchiness or tenderness]).
  • 15. Melanoma can vary in appearance
  • 19. Growth patterns of melanoma: superficial spreading melanoma – 70% nodular melanoma – 15-20% lentigo maligna melanoma – 4 -10% acral lentigo-melanoma – 2-8% amelanotic melanoma – 5%
  • 20. Biopsy techniques For cytological exam: - fine-needle aspiration, - superficial scraping. For histological exam: - complete excision (Breslow’s thickness, Clark’ levels)
  • 21. Thickness of melanoma TNM: T1 < 1 mm T2 1-2 mm T3 2-4 mm T4 > 4 mm Radial growth phase Vertical growth phase
  • 22. Evaluation for Metastasis: N0-3, M0-1 Regional Lymph Nodes: N0 – no metastasis, N1 – one lymph node with metastasis, N2 – 2-3 lymph nodes with Mts., N3 – 4 and > metastatic lymph nodes. Distant Metastasis: M0 – no metastasis, M1a: Mts in subcutaneous tissue, M1b: Mts in lung, M1c: Mts in other visceral organs (brain, liver, etc)
  • 23. Surgical treatment of primary melanoma Т3bN1аМ0: wide local excision with wound plasty.
  • 24. Postoperative wound closed by flaps’ transposition.
  • 25. melanoma Wide local excision Sentinel node biopsy, or regional lymph node dissection Metastatic cells Surgical approach to lymphogenous metastases of melanoma
  • 26. Surgery of regional lymph nodes Elective lymph node dissection is defined as removing regional lymph nodes that drain the site of the primary melanoma in the absence of any clinical evidence of nodal metastases. Elective lymph node dissection is a much-debated topic in the management of melanoma. Sentinel lymph node biopsy, a staging and possibly therapeutic procedure, is the most powerful predictor of melanoma recurrence and survival. Initially, lymphoscintigraphy is used to precisely map the draining nodal basin. Therapeutic regional lymph node dissection carried out when clinically present metastatic lymph nodes.
  • 27. Lentigo maligna melanoma (arise from Hutchinson’s freckle) 1 year after Radiation Therapy
  • 28. Melanoma: scars, recurrence, in transit Mts 1 3 2 4
  • 29. Metastatic melanoma Palliative  - therapy Hormonotherapy Supportive care
  • 30. Survival rates: J Clin Oncol 2001;19:3635-3648. Melanoma in situ: 100% survival at 5 years and 10 years. Lesions ≤1 mm: 91%–95% at 5 years; 83%–88% at 10 years Lesions 1.01–2 mm: 77%–89% at 5 years; 64%–79% at 10 years Lesions 2.01–4 mm: 63%–79% at 5 years; 51%–64% at 10 years Lesions >4 mm: 45%–67% at 5 years; 32%–54% at 10 years
  • 31. Skin cancers More than 1 million estimated new nonmelanoma skin cancers were diagnosed in the United States in 2005, a number that was nearly equivalent to the number of all other cancers diagnosed in the US the same year. Of these cases, approximately 80% are basal cell carcinoma (BCC) and 20% are squamous cell carcinoma (SCC), making cutaneous SCC the second most common skin cancer and one of the most common cancers overall in the US. BCC, T1
  • 32. The following are exposure-related risk factors in the development of cutaneous cancers: UV radiation exposure (high cumulative dose of sunshine, tanning beds, or medical UV treatments) Immunosuppression (eg, HIV), including iatrogenic immunosuppression (eg, transplant recipients) Ionizing radiation (eg, medical treatments, occupational or accidental radiation exposure) Infections (eg, HPV, osteomyelitis, acne conglobata, hidradenitis suppurativa, dissecting cellulitis of scalp, lupus vulgaris, lymphogranuloma venereum, granuloma inguinale, and chronic deep fungal infection) Chemical carcinogens (eg, arsenic, tar, polyaromatic hydrocarbons)
  • 33. Host responses that influence cutaneous SCC development include the following: Genetic susceptibility and dermatoses (eg, xeroderma pigmentosum, dystrophic epidermolysis bullosa, epidermodysplasia verruciformis, xeroderma pigmentosum, oculocutaneous albinism, dyskeratosis congenita, porokeratosis [Mibelli type, disseminated superficial actinic type, linear type], nevus sebaceous, and KID syndrome [keratitis, ichthyosis, deafness]) Susceptibility to UV radiation (eg, fair skin [Fitzpatrick skin types I and II], blond or red hair, light-colored eyes) Chronic inflammation, such as nonhealing burns or scars (eg, Marjolin ulcer, burn scar or thermal injury, venous ulcer, lymphedema, discoid lupus erythematosus, erosive oral lichen planus, lichen sclerosis et atrophicus, mutilating keratoderma, and necrobiotic lipoidica)
  • 34. The biggest cause of skin cancer is sun exposure
  • 35. SCC in situ: Clinically, lesions of SCC in situ (SCCIS) range from a scaly pink patch to a thin keratotic papule or plaque similar to an actinic keratosis. Bowen disease is a subtype of SCCIS characterized by a sharply demarcated pink plaque arising on non–sun-exposed skin (see the first image below). Erythroplasia of Queyrat refers to Bowen disease of the glans penis, which manifests as one or more velvety red plaques
  • 36. Every patient with suspected skin carcinoma should undergo a comprehensive examination, including the following: Location of lesion Size of lesion Character of lesion (smooth/nodular, vascularity, color) – SCC may appear as plaques or nodules with variable degrees of scale, crust, or ulceration Presence of ulceration Evaluation of subcutaneous tissues (depth of lesion, bony involvement) Palpation of regional lymph nodes
  • 37. Methods of morphological confirmation of skin cancer: For cytological exam: - superficial scraping - fine-needle aspiration For histological exam: complete excision (Breslow’s thickness, Clark’ levels)
  • 38. High-risk tumor features include the following: Greater than 2 mm thickness or Clark level IV or higher Perineural invasion Primary anatomic location on the ear or non–hair- bearing lip Poorly differentiated or undifferentiated cellular histology
  • 39. Precancerous lesions: Actinic (Solar) Keratosis) These small, scaly patches are caused by too much sun, and commonly occur on the head, neck, or hands, but can be found elsewhere. They can be an early warning sign of skin cancer, but it's hard to tell whether a particular patch will continue to change over time and become cancerous. Most do not, but we recommend early treatment to prevent the development of squamous cell skin cancer. Fair-skinned, blond, or red-haired people with blue or green eyes are most at risk.
  • 40. Cutaneous Horns The cutaneous horn appears as a funnel-shaped growth that extends from a red base on the skin. It is composed of compacted keratin. The size and shape of the growth can vary considerably, but most are a few millimeters in length. Squamous cell carcinoma can be found at the base. It usually occurs in fair-skinned elderly adults with a history of significant sun exposure.
  • 41. Skin cancer Clinical case: Basal Cell Carcinoma, T1N0M0 (ulcer pattern)
  • 42. Basal Cell Carcinoma Basal cell carcinoma is the most common and easiest-to-treat skin cancer. Because basal cell carcinoma spreads slowly, it occurs mostly in adults. Basal cell tumors can take on many forms, including a pearly white or waxy bump, often with visible blood vessels, on the ears, neck, or face. Tumors can also appear as a flat, scaly, flesh-colored or brown patch on the back or chest, or more rarely, a white, waxy scar.
  • 43. Skin cancer Clinical case: Ear Squamous Cell Carcinoma, T4N0M0
  • 44. TNM-Classification of Skin Cancer: Тis – carcinoma in situ Т1 –  2 cm Т2 – 2 - 5 cm Т3 – > 5 см Т4 – t-r invades cartilage, muscle, or bone. N0, N1 M0, M1
  • 45. Skin Cancer Squamous Cell Carcinoma of lower eyelid with invasion in bulbar conjunctiva, T4N0M0
  • 47. Skin Cancer Results after half course of gamma- therapy, 45 Gy
  • 48. SCC of back: scheme of surgery
  • 49. Surgery of skin cancer: flap plasty of wound after complete excision of cancer
  • 50. Skin Squamous Cell Cancer of Neck: Postoperative wound is temporary covered with Pig skin xenografts T4NxM0
  • 51. Skin Cancer: granulation wound (1), skin autografting (2) 14 day: wound after removing of xenografts
  • 52. Skin Cancer: complete recovery 12 months later